# nMARQ™ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation

> **NCT01824394** · PHASE3 · TERMINATED · sponsor: **Biosense Webster, Inc.** · enrollment: 481 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DEVICE:** nMARQ Navigation Catheters
- **DEVICE:** NaviStar ThermoCool Catheters

## Key facts

- **NCT ID:** NCT01824394
- **Lead sponsor:** Biosense Webster, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-04-01
- **Primary completion:** 2017-11-26
- **Final completion:** 2017-11-26
- **Target enrollment:** 481 (ACTUAL)
- **Why stopped:** Business Decision
- **Last updated:** 2025-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01824394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01824394, "nMARQ™ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01824394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*